Position in PFE
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$4,175,760
-$2,485,574 QoQ
Shares Held
173,412
-26.9% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
1.42%
of 13F equity value
Holder Rank
#663
of 2,822 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Monte Financial Group, LLC holds $28,595,491 across 7 Drug Manufacturers - General names. PFE ranks #4 (14.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
33,979 | $8,629,646 | |
| 2 | NVS |
Novartis AG
|
44,535 | $6,979,525 | |
| 3 | MRK |
Merck & Co., Inc.
|
51,508 | $6,618,778 | |
| 4 | PFE |
Pfizer Inc
This page
|
173,412 | $4,175,760 | |
| 5 | AZN |
Astrazeneca PLC
|
9,226 | $1,749,434 | |
| 6 | NVO |
Novo Nordisk A S
|
4,982 | $238,837 | |
| 7 | AMGN |
Amgen Inc
|
562 | $203,511 |
All Filings in PFE
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,175,760 | 173,412 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $6,661,334 | 237,227 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $5,983,171 | 240,288 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $6,589,968 | 258,633 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $5,587,320 | 230,500 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $6,387,377 | 252,067 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $5,526,915 | 208,327 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $5,656,149 | 195,444 | Shares | Sole | 2024-10-22 | |
| 2024-06-30 | $5,648,070 | 201,861 | Shares | Sole | 2024-07-22 | |
| 2024-03-31 | $5,236,896 | 188,717 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $4,742,749 | 164,736 | Shares | Sole | 2024-01-22 | |
| 2023-09-30 | $4,635,009 | 139,735 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $4,740,669 | 129,244 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $4,739,817 | 116,172 | Shares | Sole | 2023-04-26 | |
| 2022-12-31 | $5,638,859 | 110,048 | Shares | Sole | 2023-01-23 | |
| 2022-09-30 | $4,679,913 | 106,945 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $5,454,712 | 104,038 | Shares | Sole | 2022-07-20 | |
| 2022-03-31 | $5,373,467 | 103,795 | Shares | Sole | 2022-04-22 | |
| 2021-12-31 | $7,054,349 | 119,464 | Shares | Sole | 2022-01-26 | |
| 2021-09-30 | $5,280,466 | 122,773 | Shares | Sole | 2021-10-25 | |
| 2021-03-31 | $4,615,991 | 127,408 | Shares | Sole | 2021-04-30 | |
| 2020-12-31 | $3,979,381 | 108,106 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $3,913,684 | 106,640 | Shares | Sole | 2020-11-03 | |
| 2020-06-30 | $3,601,156 | 110,127 | Shares | Sole | 2020-08-03 | |
| 2020-03-31 | $3,048,180 | 93,388 | Shares | Sole | 2020-04-28 | |
| No filing history on record for this holder in this stock. | ||||||